Ads
    Related paper
  1. CONSEQUENCES OF DOPAMINERGIC AGONIST ASSOCIATED WITH BDNF TREATMENT ON BEHAVIORAL ALTERATIONS AND CYTOLOGICAL CHANGES IN AN EXPERIMENTAL MODEL OF PARKINSON DISEASE DUE TO MANGANESE EXPOSURE
  2. Alterations of Dopaminergic Synapse and Mitochondrial Structure by Parkinson’s Disease Toxins
  3. Structural and Functional Characterization of Hericium erinaceum, Manganese Peroxidase as an Antioxidant against Iron Induced Parkinson's Disease
  4. Role of Apoptosis in Cadmium Induced Dopaminergic Alterations in Rat Brain
  5. Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
  6. Pharmacotherapy in the treatment of Parkinson's disease
  7. DIAGNOSIS AND TREATMENT OF EARLY STAGE PARKINSON'S DISEASE
  8. SPECIFICS OF APPLYING PHYSICAL THERAPY TO TREATMENT OF PARKINSON DISEASE
  9. Genetic Basis and Novel Treatment Strategies in Parkinson's Disease – A Review
  10. ROLE OF LEE SILVERMAN VOICE TREATMENT (LSVT) IN PARKINSON DISEASE